CDT
Conduit Pharmaceuticals Inc.
NASDAQ: CDT · HEALTHCARE · BIOTECHNOLOGY
$2.25
-8.55% today
Updated 2026-04-29
Market cap
$13.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1,177.89
Dividend yield
—
52W range
$2 – $1,754
Volume
0.4M
Conduit Pharmaceuticals Inc. (CDT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | $213125.00 | $5000.00 | $7.22M | $4.19M | — |
| Cash & equivalents | $48555.00 | $345777.00 | $4.23M | $554000.00 | — |
| Current assets | $104163.00 | $646639.00 | $5.73M | $2.71M | — |
| Total liabilities | $192506.00 | $10.09M | $7.68M | $10.99M | — |
| Current liabilities | $192506.00 | $4.18M | $1.80M | $10.74M | — |
| Long-term debt | $749000.00 | $2.01M | — | — | — |
| Shareholder equity | $20619.00 | $-10.09M | $-457000.00 | $-6.79M | — |
| Retained earnings | $-4381.00 | $-10.77M | $-11.30M | $-29.10M | — |
| Accounts receivable | — | — | — | $489000.00 | — |
| Inventory | — | — | — | $343.10M | — |
| Goodwill | — | — | — | $1.02B | — |